Hepatic fibrosis - Therapeutic strategies

Digestion

Volumn 59, Issue 4, 1998, Pages 385-390

  Schuppan, Detlef ^a   Strobel, Deike ^a   Hahn, Eckhart G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antifibrotic agents; Hepatic fibrosis

Indexed keywords

ANTIFIBROTIC AGENT; COLCHICINE; CORTICOSTEROID; INTERFERON; LUFIRONIL; PENICILLAMINE; PENTOXIFYLLINE; PROSTAGLANDIN E; RETINOIC ACID; URSODEOXYCHOLIC ACID;

CONFERENCE PAPER; LIVER FIBROSIS; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CHOLAGOGUES AND CHOLERETICS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTERFERONS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RETINOIDS; URSODEOXYCHOLIC ACID;

EID: 0031827490     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007494     Document Type: Conference Paper

References (41)

1. 4 an adequate model of human cirrhosis? Hepatology 1984;3:112-120.
2. Tsukamoto H, Matsuoka M, French SW: Experimental models of hepatic fibrosis: An overview. Semin Liver Dis 1990;10:56-65.
3. Gerling B, Becker M, Waldschmidt J, Schuppan D: Elevated serum aminoterminal procollagen III peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J Hepatol 1996;25:79-84.
4. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D: Silymarin retards hepatic collagen accumulation in early and advanced biliary fibrosis secondary to bile duct obliteration in the rat. Hepatology 1997;26: 643-649.
5. Hayasaka A, Saisho H: Serum markers as tools to monitor liver fibrosis. Digestion 1998;59: 381-384.
6. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL: Inhibition of rat lipocyte activation in culture by interferon-γ. Hepatology 1992;16:776-784.
7. Rosenbloom J, Feldman G, Freundlich G, Jimenez SA: Transcriptional control of human diploid fibroblast collagen synthesis by interferon. Biochem Biophys Res Commun 1984; 123:365-372.
8. Castilla A, Prieto J, Fausto N: Transforming growth factors beta-1 and alfa in chronic liver disease: Effects of interferon-alfa therapy. N Engl J Med 1991;324:933-940.
9. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaud JA: Interferon-α2b therapy reduces liver fibrosis in chronic non-A non-B hepatitis: A quantitative histologie evaluation. J Hepatol 1993;18:1344-1349.
10. Guido M, Rugge M, Chemello L, Leandro G, Fattovich G, Giustina G, Cassaro M, Alberti A: Liver stellate cells in chronic viral hepatitis: The effect of Interferon therapy. J Hepatol 1996;24:301-307.
11. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J: Randomized trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremia. J Hepatol 1993;17:390-396.
12. Suou T, Hosho K, Kishimoto Y, Horie Y, Kawasaki H: Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1995;22:426-431.
13. 1 analog reduces rat hepatic and Ito cell collagen gene expression and accumulation after bile duct ligation injury. Hepatology 1993;17:707-714.
14. Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG: The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 1989;10: 801-806.
15. Lieber CS, Robins SJ, Li J, deCarli LM, Mak KM, Fasuolo LJM, Leo MA: Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994;106:152-159.
16. Jia JD, Boigk G, Bauer M, Strefeld T, Rühl M, Riecken EO, Schuppan D: Silymarin decreases type I procollagen mRNA levels in rats with secondary biliary cirrhosis. Gastroenterology 1998;114:A1265.
17. Poo JI, Feldmann J, Erlinger S, Braillon A, Gaudin C, Dumont M, Lebrec D: Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology 1992;102: 1752-1759.
18. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D: Ursodeoxycholic acid ameliorates parameters of cholestasis, but does not prevent collagen accumulation in rat secondary biliary fibrosis. Gastroenterology 1997;112:A372.
19. Preaux AM, Mallat A, Rosenbaum J, Zafrani ES, Mavier P: Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells. Hepatology 1997;26:315-322.
20. Raetsch C, Boigk G, Stroeter L, Waldschmidt J, Riecken EO, Schuppan D: Pentoxifylline inhibits hepatic collagen deposition in early but not advanced rat biliary fibrosis. Gastroenterology 1996;110:A1301.
21. Schuppan D: Vitamin A and liver fibrosis: Cure or villain? J Lab Clin Med 1992;119:590-591.
22. Mallat A, Preaux AM, Serradeil-Le Gal C, Raufaste D, Gallois C, Brenner DA, Bradham C, Maclouf J, Iourgenko V, Fouassier L, Dhumeaux D, Mavier P, Lotersztajn S: Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: A cyclic adenosine monophosphate-mediated pathway: Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. J Clin Invest 1996;98: 2771-2278.
23. Rockey DC, Chung JJ: Endothelin antagonism in experimental hepatic fibrosis: Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996;98:1381-1388.
24. Arthur MJP: Fibrosis and altered matrix degradation. Digestion 1998;59:376-380.
25. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS: Bone morphogenetic protein-1: The type I procollagen C-proteinase. Science 1996;271:360-362.
26. Lee S, Solo-Cordero DE, Kessler E, Takahara K, Greenspan DS: Transforming growth factor beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 1997;272:19059-19066.
27. Franklin TJ: Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997;29:79-89.
28. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
29. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360: 361-365.
30. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996;2: 418-423.
31. Grotendorst GR, Okochi H, Hayashi N: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1995;7:469-480.
32. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE: Effects of platelet-derived growth factor and other mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J Clin Invest 1989;84:1786-1794.
33. Schuppan D, Schmid M, Somasundaram R, Ackermann R, Nakamura T, Rühl M, Riecken EO: Collagens retain hepatocyte growth factor (HFG) in the liver extracellular matrix. Gastroenterology 1998;114:139-152.
34. Somasundaram R, Schuppan D: Platelet-de-rived growth factor (PDGF AA, AB and BB) binds to collagens type I-VI: Evidence for common collagenous epitopes. J Biol Chem 1996; 271:26884-26891.
35. Bruck R, Hershkoviz T, Lider O, Aeed H, Zaidel L, Matas Z, Barg J, Halpern Z: Inhibition of experimentally induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope. J Hepatol 1996;24:731-738.
36. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM: Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127: 2037-2048.
37. Grinnell F: Fibroblasts, myofibroblasts and wound contraction. J Cell Biol 1994;124:401-404.
38. Lin YC, Grinnell F: Decreased level to PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. J Cell Biol 1993;122:663-672.
39. Schuppan D, Somasundaram R, Dieterich W, Ehnis T, Bauer M: The extracellular matrix in cellular differentiation and proliferation; in Molecular and cell biological aspects of gastroenteropancreatic neuroendocrine tumour disease. Ann NY Acad Sci 1994;733:87-102.
40. Schuppan D, Gressner AM: Function and Metabolism of Collagens and Other Extracellular Matrix Proteins. Oxford Textbook of Clinical Hepatology, ed 2, 1998, in press.
41. Atkinson J, Ruehl M, Becker J, Ackermann R, Schuppan D: Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro. Exp Cell Res 1996;228:283-291.